LRMR
Larimar Therapeutics Inc
3.80$
-0.3%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.7% | 99.5% | 99.5% | 99.4% | 99.6% | 91.3% | 93.6% | 91.8% | 95.5% | 94.0% | 97.5% | 97.4% | |
| 49.4% | 18.8% | 24.6% | 38.6% | 40.5% | 19.4% | 65.1% | 89.1% | 21.2% | 27.9% | 16.6% | 58.6% | |
| 98.2% | 97.9% | 98.2% | 96.7% | 97.0% | 19.4% | 88.5% | 89.1% | 93.7% | 90.5% | 91.6% | 93.8% | |
| – | 0.7% | 0.3% | 0.9% | 1.3% | 3.0% | 0.0% | 0.3% | – | 0.3% | 0.5% | 0.5% | |
| – | – | 0.0% | – | – | 60.8% | 0.0% | -0.3% | – | – | – | – | |
| – | 0.5% | 0.5% | 0.5% | 0.2% | 6.9% | 4.8% | 5.7% | 0.7% | – | – | – | |
| 11.1% | 10.6% | 7.5% | 25.9% | 23.4% | 113.3% | 14.3% | 18.1% | 12.3% | 14.8% | 14.2% | 46.5% | |
| 5.9% | 8.7% | 7.5% | 6.9% | 10.9% | 113.3% | 8.6% | 11.2% | 8.5% | 9.9% | 12.2% | 44.4% | |
| 1.2% | 1.6% | 2.7% | – | 4.5% | 1.9% | 0.5% | 0.8% | 0.5% | 0.9% | 0.5% | 0.8% | |
| 2.0% | 4.0% | 2.0% | 2.9% | 0.7% | 68.0% | 2.5% | 2.1% | 1.3% | 1.3% | 1.2% | 3.6% | |
| – | 1.8% | – | 19.0% | 12.5% | 162.7% | – | – | – | – | – | – | |
| 88.9% | 89.4% | 92.5% | 74.1% | 76.6% | -13.3% | 85.7% | 81.9% | 87.7% | 85.2% | 85.8% | 53.5% | |
| -89.7% | -95.0% | -180.5% | -274.5% | -288.2% | -444.8% | -62.7% | -147.8% | -119.9% | -196.5% | -134.4% | -298.2% | |
| 2.1% | 1.2% | 1.7% | 2.2% | 2.2% | 59.9% | 11.4% | 21.8% | 20.4% | 45.8% | 30.6% | 50.0% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.